IRIS
GEBBIA, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.369
AS - Asia 2.474
EU - Europa 1.886
SA - Sud America 933
AF - Africa 68
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.264
SG - Singapore 1.092
IE - Irlanda 1.057
HK - Hong Kong 852
BR - Brasile 806
IT - Italia 183
DE - Germania 168
GB - Regno Unito 151
VN - Vietnam 150
TR - Turchia 88
FR - Francia 76
CN - Cina 66
CA - Canada 57
BD - Bangladesh 50
IN - India 49
AR - Argentina 47
FI - Finlandia 40
MX - Messico 40
CH - Svizzera 37
ZA - Sudafrica 30
NL - Olanda 29
IQ - Iraq 25
EC - Ecuador 23
RU - Federazione Russa 22
SE - Svezia 22
JP - Giappone 16
AT - Austria 15
MA - Marocco 15
CZ - Repubblica Ceca 14
PL - Polonia 14
ES - Italia 13
ID - Indonesia 13
UA - Ucraina 13
PY - Paraguay 12
VE - Venezuela 11
LT - Lituania 10
UZ - Uzbekistan 9
PK - Pakistan 8
UY - Uruguay 8
BO - Bolivia 7
KR - Corea 7
PE - Perù 7
CO - Colombia 6
SA - Arabia Saudita 6
AL - Albania 5
CL - Cile 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
LB - Libano 4
SN - Senegal 4
BE - Belgio 3
NP - Nepal 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.733
Salva come PNG Salva come JPEG
Città #
Dallas 3.210
Dublin 1.051
Hong Kong 849
Singapore 408
Boardman 376
Santa Clara 326
The Dalles 266
Ashburn 168
London 98
São Paulo 79
Istanbul 69
Los Angeles 62
Ho Chi Minh City 61
Assago 56
Munich 54
Chicago 38
Zurich 37
Helsinki 36
Hanoi 33
Rio de Janeiro 29
Milan 28
Prineville 26
Fort Worth 24
Frankfurt am Main 24
Montreal 24
Brooklyn 23
Chandler 23
New York 23
Belo Horizonte 21
Boston 20
Johannesburg 20
Amsterdam 19
San Francisco 18
Springfield 17
Naples 16
Tokyo 16
Atlanta 15
Brasília 15
Phoenix 15
Stockholm 15
Curitiba 14
Denver 14
Mexico City 13
Chennai 12
Ottawa 12
Porto Alegre 12
Washington 12
Baghdad 10
Catania 10
Dhaka 10
Quito 10
Seattle 10
Warsaw 10
Berlin 9
Brno 9
Guarulhos 9
Haiphong 9
Tashkent 9
Ankara 8
Biên Hòa 8
Charlotte 8
Düsseldorf 8
Guayaquil 8
New Delhi 8
Nuremberg 8
Shanghai 8
Beijing 7
Juiz de Fora 7
Montevideo 7
Asunción 6
Campinas 6
Campo Grande 6
Erbil 6
Goiânia 6
Itaquaquecetuba 6
Lauterbourg 6
Manaus 6
Misilmeri 6
Rome 6
Seoul 6
Sorocaba 6
Vienna 6
Amman 5
Bauru 5
Betim 5
Buenos Aires 5
Caxias do Sul 5
Columbus 5
Kyiv 5
Lima 5
Manchester 5
Moscow 5
Olomouc 5
Philadelphia 5
Praia Grande 5
Princeton 5
Recife 5
Salvador 5
Santa Cruz 5
São João de Meriti 5
Totale 8.155
Salva come PNG Salva come JPEG
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 290
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 265
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 211
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 180
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 87
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 83
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 80
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 80
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 75
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 74
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 73
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 71
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 69
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 69
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 68
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 67
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 67
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 67
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 65
5-Fluorouracil and Recombinant Alpha Interferon-2a in the Treatment of Advanced Colorectal Carcinoma: a Dose Optimization Study 65
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 65
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 64
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 64
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma 64
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 64
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group 64
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 63
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 62
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 62
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 61
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 61
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 60
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 60
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. 59
Gastric metastasis from breast cancer 58
Brain Metastasis in Endometrial Cancer: A Systematic Review 57
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 57
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 57
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial 57
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma 54
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 53
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma 53
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 53
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 51
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 47
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 47
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 47
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 45
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 45
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 43
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 43
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 42
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 41
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 41
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 41
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 41
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 41
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 40
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 40
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 39
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 39
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 38
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 38
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 38
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 37
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 37
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 37
null 37
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 37
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study 37
The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells 36
Toward a New Prognostic-Therapeutic Index in Geriatric Oncology 36
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 36
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale 35
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 35
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients 35
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 34
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases 34
Alpha interferon in the treatment of hairy cell leukemia 34
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 34
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 34
The Effectiveness of Combination Chemotherapy with Cisplatinum and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer 34
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells 34
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group 34
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma 33
Combination Chemotherapy with Cyclophosphamide, Doxorubicin and Vincristine in the Treatment of Stage III-IV Small-Cell Lung Cancer 33
Vinblastine and Interferon-Alpha-2a Regimen in the Treatment of Metastatic Renal Cell Carcinoma 33
Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: A case report 33
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 33
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy 33
Chemotherapy in Head and Neck Cancer (I): Management of Recurrent or Metastatic Disease 32
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium 32
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial 32
Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer 32
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? 32
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 32
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 32
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer 32
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study 32
Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen 32
Totale 5.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20255.303 423 366 528 100 512 470 409 278 757 561 565 334
2025/20264.613 642 2.102 1.788 81 0 0 0 0 0 0 0 0
Totale 11.086